ストックスクリーナーアプリを入手
141.16
1.55%
-2.22
アフターアワーズ：
141.16
前日終値:
$143.38
開ける：
$143.82
24時間の取引高:
708.77K
Relative Volume:
0.86
時価総額：
$10.66B
収益：
$12.82B
当期純損益:
$936.34M
株価収益率:
13.14
EPS:
10.74
ネットキャッシュフロー:
$1.47B
1週間 パフォーマンス:
-0.98%
1か月 パフォーマンス:
+3.95%
6か月 パフォーマンス:
-15.09%
1年 パフォーマンス:
+3.75%
1日の値動き範囲:
$140.81
$144.07
1週間の範囲:
$139.04
$144.25
52週間の値動き範囲:
$131.76
$179.60
Davita Inc Stock (DVA) Company Profile
DVA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
DVA
Davita Inc
|
141.16 | 10.77B | 12.82B | 936.34M | 1.47B | 10.74 |
|
HCA
Hca Healthcare Inc
|
361.12 | 90.47B | 71.59B | 5.78B | 4.95B | 22.49 |
|
THC
Tenet Healthcare Corp
|
175.06 | 16.32B | 20.52B | 1.46B | 1.41B | 15.12 |
|
FMS
Fresenius Medical Care Ag Adr
|
26.55 | 15.87B | 20.92B | 666.06M | 1.85B | 1.1422 |
|
EHC
Encompass Health Corp
|
110.01 | 11.94B | 5.51B | 494.70M | 386.40M | 4.84 |
Davita Inc Stock (DVA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-03-06 | 開始されました | Barclays | Equal Weight |
| 2023-08-07 | アップグレード | UBS | Neutral → Buy |
| 2022-11-01 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2022-10-31 | ダウングレード | UBS | Buy → Neutral |
| 2022-08-19 | 再開されました | UBS | Buy |
| 2022-06-21 | 繰り返されました | BofA Securities | Underperform |
| 2021-09-10 | 開始されました | Cowen | Market Perform |
| 2021-08-12 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2021-03-26 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2021-01-05 | ダウングレード | BofA Securities | Buy → Neutral |
| 2020-01-24 | アップグレード | Goldman | Neutral → Buy |
| 2019-11-07 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2019-10-25 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2019-09-11 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2019-07-26 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2019-01-08 | アップグレード | UBS | Sell → Neutral |
| 2019-01-03 | 開始されました | Deutsche Bank | Buy |
| 2018-12-14 | 開始されました | Barclays | Overweight |
| 2018-11-28 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2018-11-16 | 開始されました | UBS | Sell |
| 2018-11-08 | ダウングレード | Raymond James | Strong Buy → Mkt Perform |
| 2018-09-13 | アップグレード | JP Morgan | Underweight → Neutral |
| 2018-01-04 | アップグレード | BofA/Merrill | Neutral → Buy |
| 2017-12-12 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2017-12-11 | アップグレード | Citigroup | Neutral → Buy |
| 2017-12-07 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2017-11-08 | 繰り返されました | RBC Capital Mkts | Sector Perform |
| 2017-10-09 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2017-06-26 | ダウングレード | Jefferies | Buy → Hold |
| 2016-12-13 | ダウングレード | Robert W. Baird | Outperform → Neutral |
すべてを表示
Davita Inc (DVA) 最新ニュース
What drives DaVita Inc. stock priceMassive stock growth - PrintWeekIndia
What analysts say about DaVita Inc. stockMarket-crushing stock picks - PrintWeekIndia
Is DaVita Inc. a good long term investmentFree Consultation - jammulinksnews.com
DaVita Inc. Stock Analysis and ForecastFree Investment Community - jammulinksnews.com
Lobbying Update: $90,000 of DAVITA INC. lobbying was just disclosed - Quiver Quantitative
DaVita’s Quarterly Earnings Preview: What You Need to Know - MSN
DaVita Inc. Schedules 2nd Quarter 2025 Investor Conference Call - Kilgore News Herald
DaVita Amends Credit Agreement with $250M Loan - TipRanks
Allen learns about dialysis legislation - Statesboro Herald
DaVita Inc. (NYSE:DVA) Looks Inexpensive But Perhaps Not Attractive Enough - 富途牛牛
DaVita Inc. Q2 2025 Earnings Preview: What to ExpectNews and Statistics - IndexBox
DaVita’s Quarterly Earnings Preview: What You Need To Know - Barchart.com
DaVita Healthcare (DVA): Riding Out the Storm with Undervalued Potential - AInvest
DaVita HealthCare (DVA) Dips More Than Broader Market: What You Should Know - Yahoo Finance
What makes DaVita Inc. stock price move sharplyChart Breakout Alert - beatles.ru
DaVita Inc. (DVA) Stock Analysis: Unpacking the Impressive 54.79% Return on Equity and Its Implications for Investors - DirectorsTalk Interviews
DaVita's ESG Leadership: A Catalyst for Valuation Uplift in Healthcare - AInvest
DaVita Reveals Its Developments Towards ESG Goals in Its Community Care Report - Yahoo Finance
12 Best Stocks to Invest In for Good Returns - Insider Monkey
DaVita Inc (DVA:UN): Stock Price, Quote and News - BNN Bloomberg
Barclays Keeps Their Hold Rating on DaVita (DVA) - The Globe and Mail
Here's Why DaVita HealthCare (DVA) is a Strong Momentum Stock - Yahoo Finance
DaVita HealthCare (DVA) Stock Sinks As Market Gains: Here's Why - Yahoo Finance
DaVita’s SWOT analysis: dialysis provider’s stock faces volume challenges - Investing.com
Zacks Industry Outlook Highlights Quest Diagnostics, Encompass Health, DaVita and The Pennant - TradingView
Day in the Life: Jena, DaVita Social Worker - CSRwire
Why DaVita HealthCare (DVA) is a Top Value Stock for the Long-Term - Yahoo Finance
DaVita HealthCare (DVA) Rises As Market Takes a Dip: Key Facts - Yahoo Finance
DaVita Inc. (DVA) Is Down 9% This Year. Here Is Why - MSN
Is DaVita Stock Underperforming The S&P 500? - Barchart.com
DaVita Releases Annual Community Care Report, Highlights Achievements in Corporate Citizenship - CSRwire
Bernstein Adjusts Price Target on DaVita to $150 From $184, Maintains Market Perform Rating - MarketScreener
DaVita HealthCare (DVA) Outperforms Broader Market: What You Need to Know - Yahoo Finance
Government Contract Update: $206M payment to DAVITA INC - Quiver Quantitative
DaVita to offer $750M of senior notes in private offering - MSN
DaVita Inc. (NYSE:DVA) Shares Sold by Two Sigma Investments LP - Defense World
Winners And Losers Of Q1: DaVita (NYSE:DVA) Vs The Rest Of The Outpatient & Specialty Care Stocks - FinancialContent
Those who invested in DaVita (NYSE:DVA) five years ago are up 76% - simplywall.st
DaVita HealthCare (DVA) Down 3.4% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
DaVita Inc. (DVA) Announces Results of 2025 Annual Meeting of St - GuruFocus
DaVita Holds 2025 Annual Stockholders Meeting - TipRanks
Wellington Management Group LLP Raises Position in DaVita Inc. (NYSE:DVA) - Defense World
Davita Inc (DVA) 財務データ
収益
当期純利益
現金流量
EPS
0.32%
大文字化:
|
ボリューム (24 時間):